ArticleCancer science2016

Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.

Taichi Takashina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.